BioLargo's Innovations in Cleantech Begin to Yield Results
BioLargo Inc. is seeing the fruits of its long-term investments in cleantech and life sciences, with its battery storage technology and other innovations gaining traction in competitive markets.
BioLargo Inc., a cleantech and life sciences company, is beginning to reap the benefits of its extensive research and development efforts across several innovative technologies. President and CEO Dennis Calvert highlighted the company's progress during a recent interview with Benzinga, emphasizing the significance of their advancements in odor and VOC controls, PFAS groundwater remediation and treatment, battery storage technology, and medical devices.
Calvert pointed to the company's battery storage unit, Cellinity, as a particularly promising area of growth. With third-party validation now secured, Cellinity is poised to meet the increasing demand for efficient energy storage solutions, especially in support of AI expansion. The company's focus on long-term development and overcoming significant barriers to entry is now translating into tangible success, marking a pivotal moment in BioLargo's journey.
For more details on BioLargo's advancements and Calvert's insights, the full interview can be viewed here.